CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...